Chromosomal alterations of 16q22–q24 have been associated with favorable tumor characteristics such as low-grade, higher age at diagnosis, positive ER status and the luminal A subtype, which has the most favorable prognosis [19]–[21]. The gene discussed is ESR1; the disease is neoplasm.